Flumazenil does not antagonize the cardiac effects of midazolam in the isolated rat heart-lung preparation
Flumazenil does not antagonize the cardiac effects of midazolam in the isolated rat heart-lung preparation
复制标题
氟马西尼在离体大鼠心肺制剂中不拮抗咪达唑仑的心脏作用
DOI:
10.1007/bf02471389
复制
发表时间:
1996
影响因子:
2.8
通讯作者:
T. Kumazawa
中科院分区:
文献类型:
--
作者:
Toshihiro Nakamura;S. Kashimoto;A. Nonaka;T. Kumazawa
We examined the effects of midazolam and flumazenil on cardiac function and metabolism in the isolated rat heart-lung preparation. Wistar rats were divided into five groups (each group:n=8) as follows: (1) control (saline); (2) flumazenil (1.3×10−5M); (3) flumazenil (10−4M); (4) midazolam (60μg·ml−1); and (5) midazolam (60μg·ml−1) and flumazenil (1.3×10−5M). Systolic blood pressure and calculated left ventricular dP/dtmaximum in the midazolam or midazolam conbined with flumazenil groups increased significantly in comparison with those in the control group. Heart rate in the midazolam group was lower than that in the control group. However, in the flumazenil group, there were no effects on the hemodynamics. There were no significant differences in the myocardial tissue concentration of ATP, lactate, and glycogen in all groups. In this study, midazolam decreased heart rate; however, flumazenil had no effect on the heart, nor did it antagonize the cardiac effects of midazolam. These results suggest that flumazenil has no effect on the peripheraltype benzodiazepine receptor of the myocardium.